These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 12587003

  • 1. Lipolytic and nutritive blood flow response to beta-adrenoceptor stimulation in situ in subcutaneous abdominal adipose tissue in obese men.
    Schiffelers SL, Akkermans JA, Saris WH, Blaak EE.
    Int J Obes Relat Metab Disord; 2003 Feb; 27(2):227-31. PubMed ID: 12587003
    [Abstract] [Full Text] [Related]

  • 2. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M.
    Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
    [Abstract] [Full Text] [Related]

  • 3. Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men.
    Jocken JW, Goossens GH, van Hees AM, Frayn KN, van Baak M, Stegen J, Pakbiers MT, Saris WH, Blaak EE.
    Diabetologia; 2008 Feb; 51(2):320-7. PubMed ID: 18060661
    [Abstract] [Full Text] [Related]

  • 4. Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes.
    Blaak EE, Kemerink GJ, Pakbiers MT, Wolffenbuttel BH, Heidendal GA, Saris WH.
    Clin Sci (Lond); 1999 Oct; 97(4):421-8. PubMed ID: 10491342
    [Abstract] [Full Text] [Related]

  • 5. In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
    Barbe P, Stich V, Galitzky J, Kunesova M, Hainer V, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):63-9. PubMed ID: 8989234
    [Abstract] [Full Text] [Related]

  • 6. Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
    Barbe P, Galitzky J, De Glisezinski I, Riviere D, Thalamas C, Senard JM, Crampes F, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):619-25. PubMed ID: 9467583
    [Abstract] [Full Text] [Related]

  • 7. Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls.
    Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S.
    Diabetes; 2000 Dec; 49(12):2149-53. PubMed ID: 11118019
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects.
    Goossens GH, Blaak EE, Saris WH, van Baak MA.
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2690-6. PubMed ID: 15181043
    [Abstract] [Full Text] [Related]

  • 10. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V, Lönnqvist F, Thörne A, Wennlund A, Large V, Reynisdottir S, Arner P.
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
    [Abstract] [Full Text] [Related]

  • 11. No difference in the lipolytic response to beta-adrenoceptor stimulation in situ but a delayed increase in adipose tissue blood flow in moderately obese compared with lean men in the postexercise period.
    Børsheim E, Lönnroth P, Knardahl S, Jansson PA.
    Metabolism; 2000 May; 49(5):579-87. PubMed ID: 10831166
    [Abstract] [Full Text] [Related]

  • 12. Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects.
    Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME.
    Diabetologia; 2004 Aug; 47(8):1462-8. PubMed ID: 15309296
    [Abstract] [Full Text] [Related]

  • 13. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L, Langin D, Reynisdottir S, Dauzats M, Arner P.
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L, Rössner S, Hagström-Toft E, Reynisdottir S.
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [Abstract] [Full Text] [Related]

  • 16. Regional difference in lipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique.
    Iwao N, Oshida Y, Sato Y.
    Acta Physiol Scand; 1997 Dec; 161(4):481-7. PubMed ID: 9429655
    [Abstract] [Full Text] [Related]

  • 17. In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue.
    Boschmann M, Krupp G, Luft FC, Klaus S, Jordan J.
    Obes Res; 2002 Jun; 10(6):555-8. PubMed ID: 12055332
    [Abstract] [Full Text] [Related]

  • 18. In vivo lipolysis in adipose tissue from two anatomical locations measured by microdialysis.
    Portillo MP, Villaro JM, Torres MI, Macarulla MT.
    Life Sci; 2000 Jun 16; 67(4):437-45. PubMed ID: 11003053
    [Abstract] [Full Text] [Related]

  • 19. Short-term beta-adrenergic regulation of leptin, adiponectin and interleukin-6 secretion in vivo in lean and obese subjects.
    Goossens GH, Jocken JW, van Baak MA, Jansen EH, Saris WH, Blaak EE.
    Diabetes Obes Metab; 2008 Nov 16; 10(11):1029-38. PubMed ID: 18435774
    [Abstract] [Full Text] [Related]

  • 20. In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.
    Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH.
    J Pharmacol Exp Ther; 2002 Apr 16; 301(1):229-33. PubMed ID: 11907178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.